These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9767429)

  • 21. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
    Sin JI; Kim JJ; Zhang D; Weiner DB
    Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant action of murine IL-2/Ig plasmid after intramuscular immunization with Indian HIV-1 subtype C recombinant env.gp 120 construct.
    Aggarwal P; Kumar S; Vajpayee M; Seth P
    Viral Immunol; 2005; 18(4):649-56. PubMed ID: 16359231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine.
    Tsuji T; Fukushima J; Hamajima K; Ishii N; Aoki I; Bukawa H; Ishigatsubo Y; Tani K; Okubo T; Dorf ME; Okuda K
    Immunology; 1997 Jan; 90(1):1-6. PubMed ID: 9038705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
    Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
    Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory effect of a plasmid expressing CD40 ligand on DNA vaccination against human immunodeficiency virus type-1.
    Ihata A; Watabe S; Sasaki S; Shirai A; Fukushima J; Hamajima K; Inoue J; Okuda K
    Immunology; 1999 Nov; 98(3):436-42. PubMed ID: 10583605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.
    Barouch DH; Craiu A; Kuroda MJ; Schmitz JE; Zheng XX; Santra S; Frost JD; Krivulka GR; Lifton MA; Crabbs CL; Heidecker G; Perry HC; Davies ME; Xie H; Nickerson CE; Steenbeke TD; Lord CI; Montefiori DC; Strom TB; Shiver JW; Lewis MG; Letvin NL
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4192-7. PubMed ID: 10759543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.
    Baden LR; Blattner WA; Morgan C; Huang Y; Defawe OD; Sobieszczyk ME; Kochar N; Tomaras GD; McElrath MJ; Russell N; Brandariz K; Cardinali M; Graham BS; Barouch DH; Dolin R;
    J Infect Dis; 2011 Nov; 204(10):1541-9. PubMed ID: 21940420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of LIGHT expression plasmid enhances humoral and cellular immune responses to HIV-1 Nef in mice.
    Wen J; Hao W; Fan Y; Du J; Du B; Qian M; Jiang W
    Arch Virol; 2014 Jul; 159(7):1663-9. PubMed ID: 24435162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector.
    Jiang W; Jin N; Cui S; Li Z; Zhang L; Wang H; Han W
    J Virol Methods; 2006 Sep; 136(1-2):1-7. PubMed ID: 16793146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
    Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
    Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
    Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
    Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.
    Bråve A; Boberg A; Gudmundsdotter L; Rollman E; Hallermalm K; Ljungberg K; Blomberg P; Stout R; Paulie S; Sandström E; Biberfeld G; Earl P; Moss B; Cox JH; Wahren B
    Mol Ther; 2007 Sep; 15(9):1724-33. PubMed ID: 17579577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
    Shata MT; Hone DM
    J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.
    Ishii N; Fukushima J; Kaneko T; Okada E; Tani K; Tanaka SI; Hamajima K; Xin KQ; Kawamoto S; Koff W; Nishioka K; Yasuda T; Okuda K
    AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1421-8. PubMed ID: 9359662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface modified liposomes for nasal delivery of DNA vaccine.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Mehta A; Vyas SP
    Vaccine; 2008 Apr; 26(18):2225-33. PubMed ID: 18396362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model.
    Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM
    Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.